Bernstein slashes price target on Lilly[Eli] & Co [LLY] – find out why.

HAPP Stock

Lilly(Eli) & Co [NYSE: LLY] loss -6.28% or -56.75 points to close at $846.83 with a heavy trading volume of 18217088 shares.

The daily chart for LLY points out that the company has recorded 9.02% gains over the past six months.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

If we look at the average trading volume of 2.89M shares, LLY reached to a volume of 18217088 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Lilly[Eli] & Co [LLY]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LLY shares is $1020.55 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LLY stock is a recommendation set at 1.62. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Bernstein have made an estimate for Lilly(Eli) & Co shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 17, 2024. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on September 13, 2024, representing the official price target for Lilly(Eli) & Co stock. Previously, the target price had yet another raise to $1025, while Deutsche Bank analysts kept a Buy rating on LLY stock.

The Average True Range (ATR) for Lilly(Eli) & Co is set at 24.51, with the Price to Sales ratio for LLY stock in the period of the last 12 months amounting to 20.68. The Price to Book ratio for the last quarter was 59.37, with the Price to Cash per share for the same quarter was set at 3.54. Price to Free Cash Flow for LLY in the course of the last twelve months was 3121.99 with Quick ratio for the last quarter at 0.87.

Trading performance analysis for LLY stock

Lilly(Eli) & Co [LLY] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.25. With this latest performance, LLY shares dropped by -4.26% in over the last four-week period, additionally plugging by 9.02% over the last 6 months – not to mention a rise of 49.69% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LLY stock in for the last two-week period is set at 30.76, with the RSI for the last a single of trading hit 23.66, and the three-weeks RSI is set at 36.35 for Lilly(Eli) & Co [LLY]. The present Moving Average for the last 50 days of trading for this stock 915.96, while it was recorded at 886.00 for the last single week of trading, and 824.87 for the last 200 days.

Lilly[Eli] & Co [LLY]: A deeper dive into fundamental analysis

Lilly(Eli) & Co’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.87 and a Current Ratio set at 1.11.

Lilly(Eli) & Co [LLY]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for LLY. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Lilly(Eli) & Co go to 34.55%.

An analysis of Institutional ownership at Lilly[Eli] & Co [LLY]

There are presently around $83.59%, or 83.72%% of LLY stock, in the hands of institutional investors. The top three institutional holders of LLY stocks are: LILLY ENDOWMENT INC with ownership of 97.37 million shares, which is approximately 10.809%. VANGUARD GROUP INC, holding 73.86 million shares of the stock with an approximate value of $$66.87 billion in LLY stocks shares; and VANGUARD GROUP INC, currently with $$59.62 billion in LLY stock with ownership which is approximately 7.3109%.